BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:52 AM | Browse: 92 | Download: 420
 |
Received |
|
2024-09-19 14:09 |
|
Peer-Review Started |
|
2024-09-19 14:09 |
|
First Decision by Editorial Office Director |
|
2024-09-30 10:28 |
|
Return for Revision |
|
2024-09-30 10:28 |
|
Revised |
|
2024-10-07 08:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-31 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-31 11:10 |
|
Articles in Press |
|
2024-10-31 11:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-06 02:47 |
|
Publish the Manuscript Online |
|
2024-12-12 09:30 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shuai Liu and Yong-Wei Yu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yong-Wei Yu, PhD, Department of Critical Care Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310000, Zhejiang Province, China. yuyongwei@zju.edu.cn |
| Key Words |
Network pharmacology; Cancer; Multicomponent; Multitarget; Therapy |
| Core Tip |
Cancer cannot be effectively treated against a single gene target because it involves the synergy of different gene groups. Network pharmacology provides strong evidence of "multicomponent-multitarget" synergistic effects for the treatment of cancer with Chinese medicine. |
| Publish Date |
2024-12-12 09:30 |
| Citation |
Liu S, Yu YW. Network pharmacology: Changes the treatment mode of "one disease-one target" in cancer treatment. World J Gastrointest Oncol 2025; 17(1): 101581 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i1/101581.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i1.101581 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
